Company
Melbourne, VIC
Every investor coverage indicates participated in a round IDT Australia raised.
Companies IDT Australia acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming IDT Australia. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of Australian manufacturing news: IDT Australia wins a Sanofi mRNA contract, Amplia collects an R&D tax refund, OptiGrid enters EnergyLab's accelerator, plus a ship launch, hydrogen towers, road works and a job listing.
Manufacturing roundup: IDT Australia and Genetic Signatures announce capital raisings; Memphasys and Genetic Signatures appoint new chief executives; NIOA opens a US office; DefendTex holds acquisition talks with Brazil's Avibras; a cobotics PhD ends.
Melbourne pharmaceutical maker IDT Australia has won Victorian Government backing to manufacture antibody drug conjugates at a new Boronia plant, adding 25 jobs; the funding amount was not disclosed.
Australian manufacturing roundup: IDT Australia's shareholder raise, EV charger rollouts, a mining equipment hire, a plastics recycling plant completion, research collaborations and government funding moves.
Briefs roundup: space capability database launching, IDT's shareholder plan after a $5m placement, Orthocell's R&D tax refund, Ford job cuts, steel output figures, and a gate safety warning.
Australian manufacturing roundup: Titomic raises via placement, H2X signs hydrogen MoU, Austal posts a loss, Aristocrat trials cashless gaming, IDT restructures, Bisalloy reports, BAE recruits, CDU launches TAFE.
Also @AuManufacturing
IDT Australia has secured an $11.44 million federal government payment to prepare its Melbourne sterile facility for potential mRNA vaccine production, with $7.5 million already received; vaccine candidate talks with Monash continue.